DCEP regimen
Term · Oncology and biomedicine · MLC-T-ONC-012937
A regimen consisting of dexamethasone, cyclophosphamide, etoposide, and cisplatin that may be used as a salvage regimen for relapsed and/or refractory plasma cell myeloma and/or as a mobilization regimen, followed by granulocyte colony-stimulating factor (G-CSF), for peripheral blood stem cell (PBSC) collection in plasma cell myeloma.
| Identifier | MLC-T-ONC-012937 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | DCEP |
| Synonyms | dexamethasone-cyclophosphamide-etoposide-cisplatin; dexamethasone-Cytoxan-Vepesid-Platinol; dexamethasone/cyclophosphamide/etoposide/cisplatin; dexamethasone/cyclophosphamide/etoposide/cisplatin regimen |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012937",
"term": "DCEP regimen",
"field": "Oncology and biomedicine",
"definition": "A regimen consisting of dexamethasone, cyclophosphamide, etoposide, and cisplatin that may be used as a salvage regimen for relapsed and/or refractory plasma cell myeloma and/or as a mobilization regimen, followed by granulocyte colony-stimulating factor (G-CSF), for peripheral blood stem cell (PBSC) collection in plasma cell myeloma.",
"abbreviation": "DCEP",
"synonyms": [
"dexamethasone-cyclophosphamide-etoposide-cisplatin",
"dexamethasone-Cytoxan-Vepesid-Platinol",
"dexamethasone/cyclophosphamide/etoposide/cisplatin",
"dexamethasone/cyclophosphamide/etoposide/cisplatin regimen"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dcep-regimen/"
}
Record 5,729 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.